Literature DB >> 24074329

Epidemiological associations of allergy, IgE and cancer.

D H Josephs1, J F Spicer, C J Corrigan, H J Gould, S N Karagiannis.   

Abstract

Several epidemiological studies have evaluated potential associations between allergy and risk of malignancy. It remains clear that the relationship between allergy and cancer is complex. Three hypotheses have been proposed to account for observed relationships: these are chronic inflammation, immunosurveillance, prophylaxis, and we propose adding a fourth: inappropriate T-helper 2 (Th2) immune skewing. Each of these attempts to explain either the increased or decreased risk of different cancer types in 'allergic' patients reported in the literature. All four hypotheses are based on known mechanisms of allergic inflammation and/or IgE antibody functions, and uphold the view of an immunological basis for the relationship between allergy and malignancies. This review summarizes and draws conclusions from the epidemiological literature examining the relationships between specific types of cancer and allergic diseases. Particular emphasis is placed on the most recent contributions to the field, and on consideration of the allergic immune mechanisms that may influence positive or negative associations.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24074329     DOI: 10.1111/cea.12178

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  39 in total

1.  Atopic allergic conditions and pancreatic cancer risk: Results from the Multiethnic Cohort Study.

Authors:  Brian Z Huang; Loic Le Marchand; Christopher A Haiman; Kristine R Monroe; Lynne R Wilkens; Zuo-Feng Zhang; Veronica Wendy Setiawan
Journal:  Int J Cancer       Date:  2018-01-12       Impact factor: 7.396

2.  IgE/FcεRI-Mediated Antigen Cross-Presentation by Dendritic Cells Enhances Anti-Tumor Immune Responses.

Authors:  Barbara Platzer; Kutlu G Elpek; Viviana Cremasco; Kristi Baker; Madeleine M Stout; Cornelia Schultz; Eleonora Dehlink; Kai-Ting C Shade; Robert M Anthony; Richard S Blumberg; Shannon J Turley; Edda Fiebiger
Journal:  Cell Rep       Date:  2015-03-05       Impact factor: 9.423

3.  Camphor white oil induces tumor regression through cytotoxic T cell-dependent mechanisms.

Authors:  Yalda Moayedi; Sophie A Greenberg; Blair A Jenkins; Kara L Marshall; Lina V Dimitrov; Aislyn M Nelson; David M Owens; Ellen A Lumpkin
Journal:  Mol Carcinog       Date:  2019-01-20       Impact factor: 4.784

4.  Make killers sweeter: targeting metabolic checkpoints of NK cells.

Authors:  Haiming Wei; Binqing Fu
Journal:  Nat Immunol       Date:  2020-09       Impact factor: 25.606

5.  Atopic allergic conditions and colorectal cancer risk in the Multiethnic Cohort Study.

Authors:  Neal A Tambe; Lynne R Wilkens; Peggy Wan; Daniel O Stram; Frank Gilliland; S Lani Park; Wendy Cozen; Otoniel Martínez-Maza; Loic Le Marchand; Brian E Henderson; Christopher A Haiman
Journal:  Am J Epidemiol       Date:  2015-04-08       Impact factor: 4.897

Review 6.  Antibodies specific for disease-associated antigens (DAA) expressed in non-malignant diseases reveal potential new tumor-associated antigens (TAA) for immunotherapy or immunoprevention.

Authors:  Camille Jacqueline; Olivera J Finn
Journal:  Semin Immunol       Date:  2020-04-06       Impact factor: 11.130

Review 7.  Eosinophils: The unsung heroes in cancer?

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Stefania Loffredo; Valeria Lucarini; Giancarlo Marone; Fabrizio Mattei; Gianni Marone; Giovanna Schiavoni
Journal:  Oncoimmunology       Date:  2017-11-13       Impact factor: 8.110

Review 8.  IgE immunotherapy against cancer.

Authors:  Lai Sum Leoh; Tracy R Daniels-Wells; Manuel L Penichet
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

9.  History of allergy and atopic dermatitis in relation to squamous cell and Basal cell carcinoma of the skin.

Authors:  Judy Cheng; M Scot Zens; Eric Duell; Ann E Perry; M Shane Chapman; Margaret R Karagas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-02-10       Impact factor: 4.254

10.  Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Karin E Smedby; Joshua N Sampson; Jennifer J Turner; Susan L Slager; Marc Maynadié; Eve Roman; Thomas M Habermann; Christopher R Flowers; Sonja I Berndt; Paige M Bracci; Henrik Hjalgrim; Dennis D Weisenburger; Lindsay M Morton
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.